Results 121 to 130 of about 7,682,939 (300)
Overview of the Kansas Department for Aging and Disability Services [House - 2019]
"January 23, 2019."; Presentation before the Kansas Legislature, House Social Services Budget Committee, by Brad Ridley, Director of Operations/Financial and Information Services Commissioner, Kansas Department for Aging and Disability Services ...
Ridley, Brad D. 1979-
core
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks +8 more
wiley +1 more source
Overview of the Kansas Department for Aging And Disability Services
application/pdf; "February 10, 2015."; Presentation to the Kansas Legislature at a meeting of the House Social Services Budget Committee, by Kari Bruffett, Secretary, Kansas Department for Aging and Disability Services.; This is a summary version of a ...
Bruffett, Kari.
core
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Overview of the Kansas Department for Aging And Disability Services [2015]
application/pdf; "January 28, 2015."; Presentation to the Kansas Legislature at a meeting of the House Social Services Budget Committee, by Kari Bruffett, Secretary, Kansas Department for Aging and Disability Services.Presentation giving an overview of ...
Bruffett, Kari.
core
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source
Background The Coronavirus Disease 2019 (COVID-19) pandemic disrupted the capacity of healthcare systems. This study aimed to provide a better understanding of the impact of the COVID-19 pandemic on sexual and reproductive healthcare (SRH) services ...
Simone Garzon +7 more
doaj +1 more source
Parkinson Disease Subtype Stability and Eventual Convergence
ABSTRACT Objective Previous research identified distinct Parkinson disease (PD) clinical subtypes of “Motor Only,” “Psychiatric & Motor,” and “Cognitive & Motor” based on comprehensive, multidomain classification. Whether these subtypes reflect distinct trajectories or progressive disease stages remains unknown.
Laura M. Rosok +10 more
wiley +1 more source
Overview of the Kansas Department for Aging and Disability Services [Senate]
"February 20, 2019."; Presentation before the Kansas Legislature, Senate Social Services Subcommittee, by Laura Howard, Acting Secretary, Kansas Department for Aging and Disability Services.Presentation giving an overview of the Kansas Department for ...
Howard, Laura.
core
Four‐Year Cognitive Outcomes in Multiple Sclerosis: Associations With Lesion Myelin Integrity
ABSTRACT Objectives Cognitive impairment is prevalent in patients with multiple sclerosis (MS) but whether lesion myelin integrity influences future cognitive outcomes remains unclear. We investigated the relationship between baseline lesion myelin water fraction (MWF) and cognitive performance 4 years later.
Iliana Pliska‐Bloch +9 more
wiley +1 more source

